AVITA Medical, Inc. (RCEL)

NASDAQ: RCEL · IEX Real-Time Price · USD
5.55
0.02 (0.36%)
May 20, 2022 4:00 PM EDT - Market closed
Market Cap138.50M
Revenue (ttm)33.55M
Net Income (ttm)-28.61M
Shares Out24.96M
EPS (ttm)-0.21
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume81,851
Open5.60
Previous Close5.53
Day's Range5.33 - 5.72
52-Week Range5.06 - 22.49
Beta0.73
AnalystsBuy
Price Target22.24 (+300.7%)
Earnings DateMay 12, 2022

About RCEL

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professional...

IndustryBiotechnology
Employees108
Stock ExchangeNASDAQ
Ticker SymbolRCEL
Full Company Profile

Financial Performance

In 2021, AVITA Medical's revenue was 31.29 million, an increase of 72.01% compared to the previous year's 18.19 million. Losses were -26.58 million, -36.75% less than in 2020.

Financial numbers in millions AUDFinancial Statements

Analyst Forecast

According to 11 analysts, the average rating for RCEL stock is "Buy." The 12-month stock price forecast is 22.24, which is an increase of 300.72% from the latest price.

Price Target
$22.24
(300.72% upside)
Analyst Consensus: Buy
Stock Forecasts

News

AVITA Medical Reports First Quarter 2022 Financial Results

VALENCIA, Calif. and MELBOURNE, Australia, May 12, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company that is developing and commercia...

1 week ago - GlobeNewsWire

RECELL® System to be Highlighted at Upcoming Music City SCALE Multidisciplinary Dermatology Meeting

VALENCIA, Calif. and MELBOURNE, Australia, May 09, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company that is developing and commercializing...

1 week ago - GlobeNewsWire

AVITA Medical to Announce First Quarter 2022 Financial Results

VALENCIA, Calif. and MELBOURNE, Australia, April 28, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a techn...

3 weeks ago - GlobeNewsWire

RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation Annual Scientific S...

VALENCIA, Calif. and MELBOURNE, Australia, March 23, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a techn...

1 month ago - GlobeNewsWire

AVITA Medical Announces Modification of BARDA Contract to Advance Development of RECELL® System in Soft Tissue Recons...

Funds will support completion of the ongoing pivotal clinical trial Funds will support completion of the ongoing pivotal clinical trial

1 month ago - GlobeNewsWire

AVITA Medical Inks Supply Pact With Premier For RECELL System

AVITA Medical Inc (NASDAQ: RCEL) has been awarded a group purchasing agreement with Premier Inc (NASDAQ: PINC) The new agreement allows Premier members, at their discretion, to take advantage of special...

Other symbols:PINC
2 months ago - Benzinga

Avita Medical, Inc. Signs Agreement with Premier, Inc. to Supply the RECELL® System to Hospitals and Health Systems A...

Agreement ensures timely access to the RECELL System for the approximately 4,440 U.S. hospitals and health systems in Premier's network Agreement ensures timely access to the RECELL System for the appro...

2 months ago - GlobeNewsWire

AVITA Medical Reports Quarter Ending December 31, 2021, and Transition Period July 1, 2021, to December 31, 2021, Fin...

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 28, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (the “Company”), a regenerative medicine company that is developing and commercia...

2 months ago - GlobeNewsWire

The RECELL® System Receives PMDA Approval in Japan and AVITA Medical will Commercialize in Partnership with COSMOTEC,...

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a techno...

2 months ago - GlobeNewsWire

AVITA Medical to Present at the Cowen 42nd Annual Health Care Conference

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a techno...

2 months ago - GlobeNewsWire

AVITA Medical Announces FDA Approval of New RECELL® System with Improved Ease of Use

System enhanced in response to clinician workflow and usability feedback; new system simplifies process

3 months ago - GlobeNewsWire

AVITA Medical to Announce Transition Period July 1, 2021 to December 31, 2021 Financial Results

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a techno...

3 months ago - GlobeNewsWire

AVITA Medical to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 02, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a techno...

3 months ago - GlobeNewsWire

RECELL® System Data to be Presented at 44th Annual John A. Boswick Burn & Wound Care Symposium

Data presentations highlight broad clinical adoption of the RECELL® System for treatment of burn wounds Data presentations highlight broad clinical adoption of the RECELL® System for treatment of burn w...

3 months ago - GlobeNewsWire

AVITA Medical Announces Preliminary Unaudited Results for the Quarter ended December 31, 2021

VALENCIA, Calif. and MELBOURNE, Australia., Jan. 10, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (the “Company”), a regenerative medicine company that is developing and commerci...

4 months ago - GlobeNewsWire

AVITA Medical Completes Enrollment in Pivotal Trial Evaluating the RECELL® System for Soft-Tissue Reconstruction

Topline data expected in second half of 2022 Topline data expected in second half of 2022

4 months ago - GlobeNewsWire

AVITA Medical Completes Enrollment in Pivotal Trial Evaluating the RECELL® System for Repigmentation of Stable Vitiligo

Topline data expected in second half of 2022 Topline data expected in second half of 2022

5 months ago - GlobeNewsWire

AVITA Medical, Inc. Announces Adjournment of 2021 Annual Stockholder Meeting

VALENCIA, Calif. and MELBOURNE, Australia, Dec. 14, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technol...

5 months ago - GlobeNewsWire

AVITA Medical to Present at Upcoming Investor Conferences

VALENCIA, Calif., and MELBOURNE, Australia, Nov. 16, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a techn...

6 months ago - GlobeNewsWire

AVITA Medical Reports First Fiscal Quarter 2022 Financial Results

VALENCIA, Calif. and MELBOURNE, Australia, Nov. 08, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (the “Company”), a regenerative medicine company that is developing and commercia...

6 months ago - GlobeNewsWire

AVITA Medical, Inc. (RCEL) Soars 8%: Is Further Upside Left in the Stock?

AVITA Medical, Inc. (RCEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near...

6 months ago - Zacks Investment Research

Regional Burn Conferences Feature 12 RECELL® System Data Presentations by Prominent Burn Surgeons

Data underscores broad clinical utility and health economic benefits of the RECELL® System Data underscores broad clinical utility and health economic benefits of the RECELL® System

6 months ago - GlobeNewsWire

AVITA Medical to Announce Fiscal First Quarter 2022 Financial Results

VALENCIA, Calif. and MELBOURNE, Australia, Oct. 25, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a techno...

6 months ago - GlobeNewsWire

AVITA Medical to Present at the 2021 Cantor Virtual Global Healthcare Conference

VALENCIA, Calif., and MELBOURNE, Australia, Sept. 13, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a tech...

8 months ago - GlobeNewsWire

AVITA Medical to Participate at the Lake Street 2021 BIG5 Conference

VALENCIA, Calif., and MELBOURNE, Australia, Aug. 31, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a techn...

8 months ago - GlobeNewsWire